bleomicin medac 15000 i. e. (ph. eur.) prašek za raztopino za injiciranje
medac - bleomicin - prašek za raztopino za injiciranje - bleomicin 15000 i.e. / 1 viala - bleomicin
bleomicin medac 30000 i.e. (ph. eur.) prašek za raztopino za injiciranje
bleomicin - prašek za raztopino za injiciranje - bleomicin 300000 i.e. / 1 viala - bleomicin
bleomicin medac 15000 i. e. (ph. eur.) prašek za raztopino za injiciranje
medac - bleomicin - prašek za raztopino za injiciranje - bleomicin 15000 i.e. / 1 viala - bleomicin
mitomicin accord 40 mg prašek za raztopino za injiciranje/infundiranje
accord healthcare - mitomicin - prašek za raztopino za injiciranje/infundiranje - mitomicin 40 mg / 1 viala - mitomicin
celdoxome pegylated liposomal
yes pharmaceutical development services gmbh - doksorubicinijev klorid - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastična sredstva - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).
mitomicin medac 1 mg/ml prašek za raztopino za injiciranje/infundiranje ali za intravezikalno raztopino
mitomicin - prašek za intravezikalno raztopino/raztopino za injiciranje - mitomicin 1 mg / 1 ml - mitomicin
mitomicin medac 1 mg/ml prašek za raztopino za injiciranje/infundiranje ali za intravezikalno raztopino
mitomicin - prašek za intravezikalno raztopino/raztopino za injiciranje - mitomicin 1 mg / 1 ml - mitomicin
mitomicin medac 1 mg/ml prašek za raztopino za injiciranje/infundiranje ali za intravezikalno raztopino
mitomicin - prašek za intravezikalno raztopino/raztopino za injiciranje - mitomicin 1 mg / 1 ml - mitomicin
mitomicin medac 1 mg/ml prašek za raztopino za injiciranje/infundiranje ali za intravezikalno raztopino
mitomicin - prašek za intravezikalno raztopino/raztopino za injiciranje - mitomicin 1 mg / 1 ml - mitomicin
bivacyn 3.500 i.e./250 i.e. v 1 g mazilo za oko
lek d.d. - bacitracin; neomicin - mazilo za oko - bacitracin 250 i.e. / 1 g neomicin3500 i.e. / 1 g; neomicin 3500 i.e. / 1 g - kombinacije različnih antibiotikov